ScreenerHero
PREVPreveCeutical Medical Inc.
CNQ · CA · Healthcare · Biotechnology · preveceutical.com
0.0150CADMkt Cap: 6.53M $P/E: —

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventi…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
ARWR
Arrowhead Pharmaceuticals, Inc.
$12.59BUSD

Key Statistics

Company
Market Cap6.53M $
Enterprise Value9.93M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.23M $
Revenue/Share—
Last Price0.0150 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.23
EV/Revenue—
P/S—
P/B-1.50
EPS (TTM)0.00
EPS (Forward)—
52W Range
—
52W High0.0150 CAD
52W Low0.0150 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE27.08%
ROA-116.73%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.25M $
CapEx (TTM)2.16K $
FCF Margin—
FCF Yield-27.98%
Net Debt3.40M $
Net Debt/EBITDA-1.45
Balance Sheet
Debt/Equity-0.75
Current Ratio0.15
Quick Ratio0.00
Book Value/Sh-0.0100 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split5:1
Split DateMay 23, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.638.19M
Float453.47M
Insiders14.29%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short665
Short (prev mo.)1.17K
Technical
SMA 500.0166 (-9.6%)
SMA 2000.0201 (-25.4%)
Beta0.07
S&P 52W Chg18.16%
Avg Vol (30d)0
Avg Vol (10d)41.30K
Technical Indicators
RSI (14)60.5
MACD0.0004
MACD Signal-0.0002
MACD Hist.+0.0006
BB Upper0.0207 CAD
BB Middle0.0163 CAD
BB Lower0.0118 CAD
BB Width54.68%
ATR (14)0.0012 CAD
Vol Ratio (20d)0.21x